相册共1张
点击图片可以查看相册
Bcl-2 Monoclonal Antibody (Bcl-2/100), FITC, eBioscience™
- 类型：流式抗体
- 品牌：Thermo Fisher
- 种属：Human应用：Flow抗体亚型：IgG1, kappa偶联物：FITC宿主：Mouse克隆号：Bcl-2/100浓度：0.1 mg/mL
规格: 100μg
货号: BMS1028FI
价格: ¥2763.00
优惠: ¥1934.00
应用 |
建议稀释比 |
|
|
流式细胞分析 (Flow) |
Assay-Dependent |
|
产品详细信息
Description: Bcl-2 is a key regulator of apoptosis and the founding member of Bcl-2 family of apoptosis regulatory protiens. The anti-apoptotic functions of Bcl-2 is achieved by activation or inactivation of an inner mitochondrial permeability transition pore, which is involved in the regulation of matrix Ca2+, pH, and voltage.
Applications Tested: Flow Cytometry.
Excitation: 488 nm; Emission: 520 nm; Laser: Blue Laser
靶标信息
BCL-2 is a key regulator of apoptosis that functions to either inhibit or promote cell death. The BCL-2 family members are also characterized by dimerizing to further modulate apoptosis. Bag1, for example, has been found to form a heterodimer with BCL-2 resulting in the enhancement of the anti-apoptotic effect of BCL-2. Bax and Bak have been shown to play a critical role in cytochrome c release from mitochondria and thus initiate apoptosis. Bax exerts a pro-apoptotic rather than an anti-apoptotic effect on cells. Constitutive expression of BCL2, such as in the case of translocation of BCL2 to Ig heavy chain locus, is thought to be the cause of follicular lymphoma. In most follicular lymphomas, neoplastic germinal centers express high levels of BCL-2 alpha protein, whereas the normal or hyperplastic germinal centers are negative. Two transcript variants of BCL-2, produced by alternate splicing, differ in their C-terminal ends. The overexpression of BCL-2 has been linked to human cancers such as B-cell lymphoma and prostate cancer.